REQUEST A DEMO
Total
USD $0.00
Search more companies

Fenax Pharma S.R.O. (Slovakia)

Main Activities: Department Stores
Full name: Fenax Pharma S.R.O. Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Fenax Pharma S.R.O. is an enterprise located in Slovakia, with the main office in Banska Bystrica. The enterprise currently operates in the Department Stores sector. It was established on April 14, 2005. 5 - 9 (2023) employees currently work for Fenax Pharma S.R.O.. In 2023, the company reported a net sales revenue increase of 38.24%. Over the same period, its total assets grew by 13.99%. The net profit margin of Fenax Pharma S.R.O. decreased by 0.54% in 2023.

Headquarters
Kapitulska, 1
Banska Bystrica; Banskobystricky; Postal Code: 97401

Contact Details: Purchase the Fenax Pharma S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Fenax Pharma S.R.O. report to view the information.
Outstanding Shares:
Purchase the Fenax Pharma S.R.O. report to view the information.
Registered Capital:
Purchase the Fenax Pharma S.R.O. report to view the information.
Incorporation Date:
April 14, 2005
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Fenax Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
38.24%
Total operating revenue
38.24%
Operating profit (EBIT)
-69.38%
EBITDA
-63.71%
Net Profit (Loss) for the Period
N/A
Total assets
13.99%
Total equity
-0.11%
Operating Profit Margin (ROS)
-0.79%
Net Profit Margin
-0.54%
Return on Equity (ROE)
N/A
Debt to Equity Ratio
0.32%
Quick Ratio
-0.14%
Cash Ratio
-0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?